You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

alpha-1 Adrenergic Agonist Drug Class List


✉ Email this page to a colleague

« Back to Dashboard


Drugs in Drug Class: alpha-1 Adrenergic Agonist

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Exela Pharma VAZCULEP phenylephrine hydrochloride SOLUTION;INTRAVENOUS 204300-001 Jun 27, 2014 AP1 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Exela Pharma VAZCULEP phenylephrine hydrochloride SOLUTION;INTRAVENOUS 204300-002 Jun 27, 2014 AP1 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Exela Pharma VAZCULEP phenylephrine hydrochloride SOLUTION;INTRAVENOUS 204300-003 Jun 27, 2014 AP1 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Amneal Pharms PROMETHAZINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 200963-001 Aug 26, 2015 AA RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Amneal Pharms PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 040902-001 Aug 25, 2009 AA RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Genus PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 040660-001 Dec 7, 2006 AA RX No Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.